Tags

Type your tag names separated by a space and hit enter

The effect of magnesium sulfate treatment on serum cardiac troponin I levels in preeclamptic women.
Acta Obstet Gynecol Scand. 2005 Jul; 84(7):617-21.AO

Abstract

AIM

To investigate serum cardiac troponin I levels before and after magnesium sulfate treatment in preeclamptic pregnant women.

MATERIALS AND METHODS

Fifty-five pregnant women were included in the prospectively planned study. Study group patients (n = 25) were pregnant women hospitalized with a preeclampsia diagnosis while the control group (n = 30) were pregnant women with no medical or obstetric problem who had been attending the antenatal clinic. Serum cardiac troponin I levels were compared in the normal pregnant women and in preeclamptic pregnant women. These levels were also compared in the preeclamptic women before and after magnesium sulfate treatment. Mann-Whitney U-test was used for statistical analysis.

RESULTS

Groups were similar with respect to age, gravity, parity, and gestational age. The median serum cardiac troponin I levels in preeclamptic patients was 0.20 ng/ml (0.02-4.53) before treatment and 0.09 ng/ml (0.02-3.91) after treatment, while it was 0.02 ng/ml (0.0-0.05) in the control group. The serum cardiac troponin I level in the preeclamptic group was significantly high (P < 0.01), and pretreatment values in this group were significantly higher compared with post-treatment values (P < 0.01)

CONCLUSION

Cardiac troponin I is a sensitive parameter for indicating minor myocardial damage which may occur in preeclampsia and for evaluating the efficiency of magnesium sulfate treatment.

Authors+Show Affiliations

Gynecology and Obstetric Department of Ankara Numune Education and Research Hospital, Ankara, Turkey. cfatalay@superonline.comNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

15954868

Citation

Atalay, Cemal, et al. "The Effect of Magnesium Sulfate Treatment On Serum Cardiac Troponin I Levels in Preeclamptic Women." Acta Obstetricia Et Gynecologica Scandinavica, vol. 84, no. 7, 2005, pp. 617-21.
Atalay C, Erden G, Turhan T, et al. The effect of magnesium sulfate treatment on serum cardiac troponin I levels in preeclamptic women. Acta Obstet Gynecol Scand. 2005;84(7):617-21.
Atalay, C., Erden, G., Turhan, T., Yildiran, G., Saraçoglu, O. F., & Koca, Y. (2005). The effect of magnesium sulfate treatment on serum cardiac troponin I levels in preeclamptic women. Acta Obstetricia Et Gynecologica Scandinavica, 84(7), 617-21.
Atalay C, et al. The Effect of Magnesium Sulfate Treatment On Serum Cardiac Troponin I Levels in Preeclamptic Women. Acta Obstet Gynecol Scand. 2005;84(7):617-21. PubMed PMID: 15954868.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The effect of magnesium sulfate treatment on serum cardiac troponin I levels in preeclamptic women. AU - Atalay,Cemal, AU - Erden,Gönül, AU - Turhan,Turan, AU - Yildiran,Gülbin, AU - Saraçoglu,O Ferit, AU - Koca,Yüksel, PY - 2005/6/16/pubmed PY - 2005/8/5/medline PY - 2005/6/16/entrez SP - 617 EP - 21 JF - Acta obstetricia et gynecologica Scandinavica JO - Acta Obstet Gynecol Scand VL - 84 IS - 7 N2 - AIM: To investigate serum cardiac troponin I levels before and after magnesium sulfate treatment in preeclamptic pregnant women. MATERIALS AND METHODS: Fifty-five pregnant women were included in the prospectively planned study. Study group patients (n = 25) were pregnant women hospitalized with a preeclampsia diagnosis while the control group (n = 30) were pregnant women with no medical or obstetric problem who had been attending the antenatal clinic. Serum cardiac troponin I levels were compared in the normal pregnant women and in preeclamptic pregnant women. These levels were also compared in the preeclamptic women before and after magnesium sulfate treatment. Mann-Whitney U-test was used for statistical analysis. RESULTS: Groups were similar with respect to age, gravity, parity, and gestational age. The median serum cardiac troponin I levels in preeclamptic patients was 0.20 ng/ml (0.02-4.53) before treatment and 0.09 ng/ml (0.02-3.91) after treatment, while it was 0.02 ng/ml (0.0-0.05) in the control group. The serum cardiac troponin I level in the preeclamptic group was significantly high (P < 0.01), and pretreatment values in this group were significantly higher compared with post-treatment values (P < 0.01) CONCLUSION: Cardiac troponin I is a sensitive parameter for indicating minor myocardial damage which may occur in preeclampsia and for evaluating the efficiency of magnesium sulfate treatment. SN - 0001-6349 UR - https://www.unboundmedicine.com/medline/citation/15954868/The_effect_of_magnesium_sulfate_treatment_on_serum_cardiac_troponin_I_levels_in_preeclamptic_women_ L2 - https://doi.org/10.1111/j.0001-6349.2005.00667.x DB - PRIME DP - Unbound Medicine ER -